Review: IFN-α/β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry

Type I interferons (IFNs), which include the IFN-αs, IFN-β, IFN-ω, IFN-κ, and IFN-τ, are an evolutionarily conserved group of secreted cytokines that serve as potent extracellular mediators of host defense and homeostasis. Binding of IFNs to specific cell surface receptors results in the activation of multiple intracellular signaling cascades, leading to the synthesis of proteins that mediate antiviral, growth inhibitory and immunomodulatory responses. In the past decade, considerable information has accumulated pertaining to the different signaling pathways that are activated by the type I IFNs. Although many of the literature findings are specific to defined cell systems or are tissue restricted, the intent of this review is to place these signaling cascades and their effectors in the context of distinct biologic outcomes.

[1]  L. Cantley,et al.  Phosphatidylinositol 3-Kinase Confers Resistance to Encephalomyocarditis and Herpes Simplex Virus-Induced Cell Death Through the Activation of Distinct Downstream Effectors1 , 2001, The Journal of Immunology.

[2]  M. J. Cody,et al.  TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.

[3]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.

[4]  L. Platanias,et al.  The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. , 2000, The Journal of biological chemistry.

[5]  S. Feller Crk family adaptors–signalling complex formation and biological roles , 2001, Oncogene.

[6]  N. Sonenberg,et al.  The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.

[7]  M. Katze,et al.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.

[8]  J. Darnell STATs and gene regulation. , 1997, Science.

[9]  M. Grace,et al.  Interferon‐α as an immunotherapeutic protein , 2002, Journal of Leukocyte Biology.

[10]  G. Stark,et al.  Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. , 1995, The EMBO journal.

[11]  G. Kochs,et al.  Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein , 1996, Journal of virology.

[12]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[13]  L. Platanias,et al.  Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. , 1994, The Journal of biological chemistry.

[14]  M. Cooper,et al.  Impairment of  T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.

[15]  T. Mak,et al.  Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.

[16]  H. Atkins,et al.  Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.

[17]  D. Choubey,et al.  Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. , 2000, Journal of biological regulators and homeostatic agents.

[18]  M. Barbacid,et al.  Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.

[19]  G. Sen,et al.  Viruses and interferons. , 2001, Annual review of microbiology.

[20]  J. Darnell,et al.  ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Kimchi Cytokine triggered molecular pathways that control cell cycle arrest , 1992, Journal of cellular biochemistry.

[22]  V. Rivera,et al.  Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β , 2001, Journal of Neuroimmunology.

[23]  M J Clemens,et al.  The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[24]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[25]  K. Schuebel,et al.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.

[26]  M. Esteban,et al.  Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action , 2000, Apoptosis.

[27]  L. Platanias,et al.  Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .

[28]  L. Platanias,et al.  A Region of the β Subunit of the Interferon α Receptor Different from Box 1 Interacts with Jak1 and Is Sufficient to Activate the Jak-Stat Pathway and Induce an Antiviral State* , 1997, The Journal of Biological Chemistry.

[29]  O. Haller,et al.  Enhanced virus resistance of transgenic mice expressing the human MxA protein , 1995, Journal of virology.

[30]  G. Stark,et al.  Characterization of β-R1, a Gene That Is Selectively Induced by Interferon β (IFN-β) Compared with IFN-α* , 1996, The Journal of Biological Chemistry.

[31]  C. Heusser,et al.  Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.

[32]  J. Gutterman,et al.  Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1). , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  I. Julkunen,et al.  IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.

[34]  S. Landolfo,et al.  The Ifi 200 genes: an emerging family of IFN-inducible genes. , 1998, Biochimie.

[35]  B. Zhivotovsky,et al.  Mechanisms of Interferon-alpha induced apoptosis in malignant cells , 2002, Oncogene.

[36]  L. Platanias,et al.  Interaction of the Transcriptional Activator Stat-2 with the Type I Interferon Receptor (*) , 1995, The Journal of Biological Chemistry.

[37]  Y. Furukawa,et al.  Transcriptional repression of the E2F-1 gene by interferon-α is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes , 1999, Oncogene.

[38]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[39]  Robert H. Silverman,et al.  Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways , 2000, Molecular and Cellular Biology.

[40]  T. Taniguchi,et al.  Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β  , 2001, European journal of immunology.

[41]  M. Dallman,et al.  Impaired Antiviral Response and Alpha/Beta Interferon Induction in Mice Lacking Beta Interferon , 2000, Journal of Virology.

[42]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[43]  E. Fish,et al.  The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[44]  R. Silverman,et al.  Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.

[45]  P. Moore,et al.  Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes* , 2001, The Journal of Biological Chemistry.

[46]  B. Williams,et al.  PKR; a sentinel kinase for cellular stress , 1999, Oncogene.

[47]  M. White,et al.  The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. , 1998, Recent progress in hormone research.

[48]  Amit Verma,et al.  The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells* , 2001, The Journal of Biological Chemistry.

[49]  B. Williams,et al.  Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.

[50]  R. Kumar,et al.  Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2. , 2000, Biochemical and biophysical research communications.

[51]  J. Trapani,et al.  The Human Interferon-inducible Protein, IFI 16, Is a Repressor of Transcription* , 1998, The Journal of Biological Chemistry.

[52]  S. Manna,et al.  IFN-α Suppresses Activation of Nuclear Transcription Factors NF-κB and Activator Protein 1 and Potentiates TNF-Induced Apoptosis1 , 2000, The Journal of Immunology.

[53]  O. Haller,et al.  Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.

[54]  L. Platanias,et al.  The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. , 2002, Biochemical and biophysical research communications.

[55]  D. Hober,et al.  Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. , 2001, Virology.

[56]  P. Roberts,et al.  Alpha/Beta Interferons Potentiate Virus-Induced Apoptosis through Activation of the FADD/Caspase-8 Death Signaling Pathway , 2000, Journal of Virology.

[57]  N. Reich,et al.  Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. Platanias,et al.  Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. , 1992, The Journal of biological chemistry.

[59]  Abhrajyoti Ghosh,et al.  A Specific Isozyme of 2′-5′ Oligoadenylate Synthetase Is a Dual Function Proapoptotic Protein of the Bcl-2 Family* , 2001, The Journal of Biological Chemistry.

[60]  D. Grandér,et al.  Molecular mechanisms underlying interferon-α-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins , 1999, Oncogene.

[61]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[62]  P. Marrack,et al.  Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.

[63]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[64]  J. Gutterman,et al.  Inhibition of E2F-4/DP-1-stimulated transcription by p202 , 1997, Oncogene.

[65]  D. Grandér,et al.  Mechanisms of interferon-induced cell cycle arrest. , 2000, Frontiers in bioscience : a journal and virtual library.

[66]  S. Landolfo,et al.  The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation , 2000, Oncogene.

[67]  S. Gupta,et al.  IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. , 1999, Journal of immunology.

[68]  T. Giese,et al.  Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12 , 2001 .

[69]  G. Kochs,et al.  Self-assembly of Human MxA GTPase into Highly Ordered Dynamin-like Oligomers* , 2002, The Journal of Biological Chemistry.

[70]  A. Verma,et al.  Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.

[71]  I. Cremer,et al.  A non‐classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs , 2002, FEBS letters.

[72]  O. Colamonici,et al.  Cloning and Expression of a Long Form of the β Subunit of the Interferon αβ Receptor That Is Required for Signaling (*) , 1995, The Journal of Biological Chemistry.

[73]  B. Hallberg,et al.  Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase , 2001 .

[74]  L. Platanias,et al.  Engagement of the CrkL adaptor in interferon α signalling in BCR–ABL‐expressing cells , 2001 .

[75]  T. C. Wagner,et al.  The Human Type I Interferon Receptor , 1996, The Journal of Biological Chemistry.

[76]  L. Platanias,et al.  Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. , 1994, The Journal of biological chemistry.

[77]  M. White,et al.  Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*) , 1995, The Journal of Biological Chemistry.

[78]  A. Pizzey,et al.  p130, p107, and pRb Are Differentially Regulated in Proliferating Cells and during Cell Cycle Arrest by α-Interferon* , 1998, The Journal of Biological Chemistry.

[79]  A. Aguzzi,et al.  Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.

[80]  E. Raz,et al.  Type I interferon is required to mount an adaptive response to immunostimulatory DNA , 2001, European journal of immunology.

[81]  B. Williams,et al.  Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[82]  S. Vidal,et al.  Functional diversity of Mx proteins: variations on a theme of host resistance to infection. , 2002, Genome research.

[83]  V. ter meulen,et al.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells , 1994, Journal of virology.

[84]  K. Pang,et al.  Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.

[85]  R. Silverman,et al.  A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.

[86]  Abhrajyoti Ghosh,et al.  Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. , 2000, Virology.

[87]  M. Karin,et al.  JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.

[88]  H. Kitayama,et al.  Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G , 1995, Molecular and cellular biology.

[89]  O. Colamonici,et al.  Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase , 1994, Molecular and cellular biology.

[90]  A. Kimchi,et al.  Close link between reduction of c-myc expression by interferon and G0/G1 arrest , 1985, Nature.

[91]  S. Goodbourn,et al.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.

[92]  D. J. Van Den Berg,et al.  CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. , 1999, Experimental hematology.

[93]  B. Schumacher,et al.  Vesicular stomatitis virus transcription inhibited by purified MxA protein. , 1995, Virology.

[94]  D. Rebouillat,et al.  The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[95]  C. Bréchot,et al.  Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein , 2001, Journal of Virology.

[96]  O. Colamonici,et al.  The type-I interferon receptor. The long and short of it. , 1996, Cytokine & growth factor reviews.

[97]  M. Katze,et al.  Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of virology.

[98]  Pavel Kovarik,et al.  Serine phosphorylation of STATs , 2000, Oncogene.

[99]  B. Williams,et al.  NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase , 2000, Molecular and Cellular Biology.

[100]  A. Verma,et al.  Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.

[101]  V. Steunou,et al.  p95vav associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-α in megakaryocytic cell lines , 2000, Oncogene.

[102]  P. Lengyel,et al.  Binding of an Interferon-inducible Protein (p202) to the Retinoblastoma Protein (*) , 1995, The Journal of Biological Chemistry.

[103]  A. Gamero,et al.  Vanadate Facilitates Interferon α-mediated Apoptosis That Is Dependent on the Jak/Stat Pathway* , 2001, The Journal of Biological Chemistry.

[104]  P. Cresswell,et al.  Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[105]  L. Platanias,et al.  The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of the CrkL Adaptor Protein* , 1997, The Journal of Biological Chemistry.

[106]  A. Lukashin,et al.  Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[107]  L. Platanias,et al.  Activation of a CrkL-Stat5 Signaling Complex by Type I Interferons* , 1999, The Journal of Biological Chemistry.

[108]  S. Harroch,et al.  Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN‐alpha and IFN‐beta. , 1994, The EMBO journal.

[109]  G. Kochs,et al.  Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus , 1995, Journal of virology.

[110]  J. Darnell,et al.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. , 1992, Science.

[111]  B. Williams,et al.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.

[112]  F. Chisari,et al.  Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.

[113]  M. White,et al.  Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. , 1997, Journal of immunology.

[114]  L. Platanias,et al.  Differential Use of the βL Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNα2 and IFNβ* , 1998, The Journal of Biological Chemistry.

[115]  F. Sallusto,et al.  Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.

[116]  A. Klöti,et al.  Human MxA Protein Confers Resistance to Semliki Forest Virus and Inhibits the Amplification of a Semliki Forest Virus-Based Replicon in the Absence of Viral Structural Proteins , 1998, Journal of Virology.

[117]  Y. Furukawa,et al.  Modulation of E2F Activity Is Linked to Interferon-induced Growth Suppression of Hematopoietic Cells* , 1997, The Journal of Biological Chemistry.

[118]  N. Sonenberg,et al.  Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. , 1999, Virology.

[119]  G R Stark,et al.  Formation of STAT1-STAT2 Heterodimers and Their Role in the Activation of IRF-1 Gene Transcription by Interferon- (*) , 1996, The Journal of Biological Chemistry.

[120]  M. de Carli,et al.  IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. , 1992, Journal of immunology.

[121]  L. Platanias,et al.  Association of the Interferon- dependent Tyrosine Kinase Tyk-2 with the Hematopoietic Cell Phosphatase (*) , 1995, The Journal of Biological Chemistry.

[122]  O. Colamonici,et al.  p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. , 1994, The Journal of biological chemistry.

[123]  R. Silverman,et al.  The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis , 1998, Cell Death and Differentiation.

[124]  M. White,et al.  The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2 (*) , 1996, The Journal of Biological Chemistry.

[125]  B. Williams,et al.  The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.

[126]  C. Biron Interferons α and β as Immune Regulators—A New Look , 2001 .

[127]  P. Roberts,et al.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.

[128]  R. Zinkernagel,et al.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors , 1995, Journal of virology.

[129]  M. White,et al.  The IRS-1 signaling system. , 1994, Trends in biochemical sciences.

[130]  J. Darnell,et al.  Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.